ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 3958183

Prognostic role of antibody reactivity to melanoma.

Vlock DR and 2 others. J Clin Invest, 1986. Cited by 19 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Prognostic role of antibody reactivity to melanoma. Papers, record 3958183. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3958183

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Prognostic role of antibody reactivity to melanoma.
PubMed
Journal
J Clin Invest
PubMed
Year
1986
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
19
iCite
Relative citation ratio, by iCite
0.72
iCite
Revised in PubMed
2018-11-13
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Vlock DRD R
2DerSimonian RR
3Kirkwood JMJ M

Source PubMed

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AntibodiesMajor topic
MelanomaMajor topic
Adult
Aged
Antibody Specificity
Cell Line
Enzyme-Linked Immunosorbent Assay
Female
Humans
Male
Middle Aged
Prognosis
Skin Pigmentation

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References28

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
180,012Study of antibodies against human melanoma produced by somatic cell hybrids.Proc Natl Acad Sci U S A1978https://conductscience.org/library/papers/80012PubMed
3283,420Serological analysis of cell surface antigens of malignant human brain tumors.Proc Natl Acad Sci U S A1978https://conductscience.org/library/papers/283420PubMed
4313,568AU cell-surface antigen of human malignant melanoma: solubilization and partial characterization.Proc Natl Acad Sci U S A1979https://conductscience.org/library/papers/313568PubMed
56,929,544Identification of a cell surface protein, p97, in human melanomas and certain other neoplasms.Proc Natl Acad Sci U S A1980https://conductscience.org/library/papers/6929544PubMed
67,004,632Cancer immunology: the search for specificity--G. H. A. Clowes Memorial lecture.Cancer Res1981https://conductscience.org/library/papers/7004632PubMed
77,451,981Tumor-associated antigens in spent medium of human melanoma cells: immunochemical characterization with xenoantisera.J Immunol1981https://conductscience.org/library/papers/7451981PubMed
85,477,666Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma.Ann Surg1970https://conductscience.org/library/papers/5477666PubMed
95,288,389Suggestive evidence that the "blocking antibodies" of tumor-bearing individuals may be antigen--antibody complexes.Proc Natl Acad Sci U S A1971https://conductscience.org/library/papers/5288389PubMed
104,364,717Inhibition of hepatoma-immune lymph-node cell cytotoxicity by tumour-bearer serum, and solubilized hepatoma antigen.Int J Cancer1973https://conductscience.org/library/papers/4364717PubMed
111,067,619Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells.Proc Natl Acad Sci U S A1976https://conductscience.org/library/papers/1067619PubMed

1 to 10 of 28

See all 28 references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.

PMIDTitleJournalYearIn PapersSource
21,911,918New perspectives on the role of vitiligo in immune responses to melanoma.Oncotarget2011https://conductscience.org/library/papers/21911918PubMed
3,384,949Isolation and partial characterization of melanoma-associated antigens identified by autologous antibody.J Clin Invest1988https://conductscience.org/library/papers/3384949PubMed
2,175,672Human IgG and IgM monoclonal antibodies against autologous melanoma produced by Epstein-Barr-virus-transformed B lymphocytes.Cancer Immunol Immunother1990https://conductscience.org/library/papers/2175672PubMed
1,540,979Serial studies of autologous antibody reactivity to squamous cell carcinoma of the head and neck.Cancer Immunol Immunother1992https://conductscience.org/library/papers/1540979PubMed

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3958183

GET https://conductscience.org/api/papers/v1/3958183/references?page=2

API referenceFor AI assistants